Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XcelerateXCRT -2.36% 9-Day RSI is 63.68 as of Aug. 03, 2026. The stock has 4 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Xcelerate ranks worse than 84.46% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-08-03), Xcelerate's 9-Day RSI is 63.68.
The industry rank for Xcelerate's 9-Day RSI or its related term are showing as below:
XCRT's 9-Day RSI is ranked worse than 84.46% of 695
companies
in the Healthcare Providers & Services industry
Industry Median: 48.43
vs XCRT: 63.68
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Xcelerate 9-Day RSI Related Terms
XCRT vs RHEP, NIVF, VLXC: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Xcelerate's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xcelerate 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Xcelerate's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Xcelerate's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xcelerate (XCRT) has a 9-Day RSI of 63.68 as of Aug. 03, 2026. According to the industry distribution chart, Xcelerate ranks #587 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 84.5%.
Is Xcelerate's 9-Day RSI too high?
Xcelerate's current 9-Day RSI is 63.68. The Healthcare Providers & Services industry median 9-Day RSI is 48.43. Xcelerate's value of 63.68 is 31.5% above this industry median. Based on the distribution chart, Xcelerate ranks #587 out of 695 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Xcelerate's 9-Day RSI compare to RHEP and NIVF?
According to the Healthcare Providers & Services industry distribution chart, Xcelerate ranks #587 out of 695 companies for 9-Day RSI. This places Xcelerate in the lower half of its industry. The industry median 9-Day RSI is 48.43. Xcelerate's value of 63.68 is 31.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 48.43, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xcelerate's current 9-Day RSI of 63.68 is 31.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 48.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xcelerate's current 9-Day RSI is 63.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xcelerate stock overvalued right now?
Xcelerate (XCRT) has a current 9-Day RSI of 63.68. The current 9-Day RSI is 63.68 and 31.5% above the Healthcare Providers & Services industry median of 48.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Xcelerate (XCRT), the current 9-Day RSI is 63.68 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Xcelerate Inc is a healthcare services and products company engaged in three separate but related businesses within the medical, health, and wellness sectors. It is focused on the development of medical technology and the provision of virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through technology. The company is also involved in the formulation, packaging, and marketing of consumer health and beauty, clinically tested skin and hair care products, and owns and licenses the rights to various forms of medical equipment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCRT has been successfully added to your 
